Schrodinger (SDGR) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$259.0M

Revenue (quarter)

$58.9M

Revenue growth (year over year)

+7.54%

Gross profit (trailing twelve months)

$147.3M

Gross margin

56.87%

Net income (trailing twelve months)

−$54.3M

Net income (quarter)

$6.0M

Net income growth (year over year)

+113.84%

Net margin

−20.98%

Return on equity

−16.18%

EPS (trailing twelve months)

−$0.73

Book value per share

$4.40

P/E (trailing twelve months)

—

Price to book

5.57

Debt to assets

48.63%

Payout ratio

—

Dividend yield

—

Company profile

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

• Is Schrodinger (SDGR) profitable?

  No. Schrodinger reported a net loss of $54.3M over the trailing twelve months.

• How much revenue does Schrodinger (SDGR) make?

  Schrodinger generated $259.0M in revenue over the trailing twelve months, up 7.54% year over year.

• How do I buy stock in Schrodinger (SDGR)?

  SDGR trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.